The administration of the synthetic peptide YMESRADR with a low aspirin dose significantly augments its antiplatelet effect, in contrast to the highly constrained peptide (S,S) PSRCDCR-NH2. An experimental study
Title:
The administration of the synthetic peptide YMESRADR with a low aspirin dose significantly augments its antiplatelet effect, in contrast to the highly constrained peptide (S,S) PSRCDCR-NH2. An experimental study
Author:
Englezopoulos, K.V. Stathopoulou, E.M. Moussis, V. Chantzichristos, V.G. Papamichael, N.D. Tatsidou, P.T. Roussa, V.D. Tsoumani, M.E. Lakkas, L. Rammos, A. Katsouras, C.S. Fotou, E. Tsikaris, V. Tselepis, A.D. Michalis, L.K.